Toward an AI-Enabled Supply Chain: Sanofi Partners with Bluecrux to Transform Global Operations

Modern Medical Research Laboratory

The customer

Sanofi, a global healthcare leader, is dedicated to discovering, developing, and delivering life-saving medicines and vaccines. With operations in over 90 countries, a workforce of 90,000 employees, and a vast supply network, Sanofi delivers over 5 billion doses annually to 11 million people. Managing such a large and complex supply chain requires continuous innovation to meet the evolving demands of the pharmaceutical industry.

As shared during our joint presentation at the Gartner Supply Chain Symposium|Xpo 2024, Sanofi recognized the need to enhance its digital capabilities to build a more agile and resilient supply chain. To tackle these challenges, they partnered with Bluecrux and implemented Axon, Bluecrux’s AI-enabled digital supply chain twin technology. This collaboration has helped Sanofi revolutionize its operations, driving long-term efficiency and adaptability in an increasingly complex global market.

Discover Sanofi’s perspective on Axon (video) ↓

  • Challenges

    • Sanofi’s supply chain spans 60 internal manufacturing sites, over 200 distribution centers, and thousands of suppliers, making it one of the largest and most intricate in the pharmaceutical industry.
    • Decades of growth and acquisitions resulted in a complex IT landscape with multiple ERP systems and various isolated data silos, leading to difficulties managing and harmonizing information across the company.
    • With data scattered across different systems, Sanofi struggled to get an accurate, end-to-end view of their supply chain.
    • Without near real-time insights into inventory levels, production lead times or supply chain bottlenecks, Sanofi faced challenges in optimizing processes and responding quickly to disruptions.
    • The lack of a foundation hindered cross-functional teams from collaborating effectively, leading to inefficiencies in decision-making.
  • Solutions

    • AI-driven data harmonization: Automated AI models connect and harmonize data from multiple ERP systems, ensuring consistency, accuracy, and improve decision-making.
    • Scalable digital transformation: In just three months, Sanofi captured 40% of its business in Axon, scaling to 100% within eight months to enable dynamic, self-adjusting planning parameters.
    • End-to-end visibility: Bluecrux’s Axon technology created a near real-time digital twin of Sanofi’s global supply chain, integrating data from all systems for full transparency and control.
    • Optimized inventory & lead times: AI-powered insights helped balance cash flow with service levels while monitoring lead times to improve responsiveness and mitigate disruptions.
    • AI-driven decision-making: Axon’s insights are made accessible to 23,000 employees daily through its integration with Plai, enabling faster and more informed supply chain decisions.
  • Results

    • The digital twin provides near real-time insights into supply flows, lead times and inventory across all regions, enabling Sanofi to respond more quickly to changes and disruptions.

    • AI insights helped Sanofi adjust planning parameters and stock levels, reducing excess inventory and freeing up working capital.

    • By identifying bottlenecks and optimizing lead times, Sanofi can get products to market more quickly, ensuring patients receive critical medicines faster.

    • AI-driven automation reduced manual tasks, allowing teams to focus on high-value activities and improved overall operational efficiency.

    • With Axon as a foundation within the supply chain, Sanofi can unlock future opportunities to harness the value of AI—ranging from carbon management and risk mitigation to resilience building and beyond.

The Bluecrux team members shine with passion every day while delivering results. With Axon, they make the promise of a digital supply chain twin real. It shows us our real supply chain and helps to unlock pockets of improvement. And this is what makes the difference.
Christophe Lescroart
Agriculture & Industry Director at Tereos

Check Our Free Webinar

Watch Here